{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,28]],"date-time":"2026-02-28T19:25:41Z","timestamp":1772306741593,"version":"3.50.1"},"reference-count":86,"publisher":"Public Library of Science (PLoS)","issue":"4","license":[{"start":{"date-parts":[[2016,4,15]],"date-time":"2016-04-15T00:00:00Z","timestamp":1460678400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["NINDS P30 NS045758-06"],"award-info":[{"award-number":["NINDS P30 NS045758-06"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006928","name":"The Ohio State University","doi-asserted-by":"crossref","award":["start-up funds"],"award-info":[{"award-number":["start-up funds"]}],"id":[{"id":"10.13039\/100006928","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000968","name":"American Heart Association","doi-asserted-by":"publisher","award":["16POST27760155"],"award-info":[{"award-number":["16POST27760155"]}],"id":[{"id":"10.13039\/100000968","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0153694","type":"journal-article","created":{"date-parts":[[2016,4,15]],"date-time":"2016-04-15T17:29:35Z","timestamp":1460741375000},"page":"e0153694","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":9,"title":["The Effect of Sorafenib, Tadalafil and Macitentan Treatments on Thyroxin-Induced Hemodynamic Changes and Cardiac Abnormalities"],"prefix":"10.1371","volume":"11","author":[{"given":"Nancy S.","family":"Saad","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kyle","family":"Floyd","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amany A. E.","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter J.","family":"Mohler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul M. L.","family":"Janssen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammad T.","family":"Elnakish","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2016,4,15]]},"reference":[{"issue":"2","key":"ref1","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.yjmcc.2005.03.020","article-title":"L-Thyroxine activates Akt signaling in the heart","volume":"39","author":"JA Kuzman","year":"2005","journal-title":"Journal of molecular and cellular cardiology"},{"issue":"4","key":"ref2","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1152\/japplphysiol.00515.2005","article-title":"Effects of induced hyperthyroidism in normal and cardiomyopathic hamsters","volume":"99","author":"JA Kuzman","year":"2005","journal-title":"Journal of Applied Physiology"},{"issue":"5","key":"ref3","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1530\/EJE-12-0627","article-title":"Mechanisms in endocrinology: Heart failure and thyroid dysfunction","volume":"167","author":"B Biondi","year":"2012","journal-title":"European Journal of Endocrinology"},{"key":"ref4","article-title":"Role of Oxidative Stress in Thyroid Hormone-Induced Cardiomyocyte Hypertrophy and Associated Cardiac Dysfunction: an Undisclosed Story","author":"MT Elnakish","journal-title":"Role of Oxidative Stress in Thyroid Hormone-Induced Cardiomyocyte Hypertrophy and Associated Cardiac Dysfunction: an Undisclosed Story"},{"issue":"4","key":"ref5","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1530\/EJE-11-0299","article-title":"A critical review and meta-analysis of the association between overt hyperthyroidism and mortality","volume":"165","author":"F Brandt","year":"2011","journal-title":"European Journal of Endocrinology"},{"issue":"5","key":"ref6","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/S0022-2828(88)80129-9","article-title":"Regional changes in myocyte size during the reversal of thyroid-inducedcardiac hypertrophy","volume":"20","author":"SE Campbell","year":"1988","journal-title":"Journal of molecular and cellular cardiology"},{"issue":"6","key":"ref7","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/0022-2828(89)90827-4","article-title":"Differential effects of triiodothyronine on rat left and right ventricular function and the influence of metoprolol","volume":"21","author":"W Zierhut","year":"1989","journal-title":"Journal of molecular and cellular cardiology"},{"issue":"6","key":"ref8","doi-asserted-by":"crossref","first-page":"2630","DOI":"10.1016\/j.ijcard.2012.06.129","article-title":"Effects of multikinase inhibitors on pressure overload-induced right ventricular remodeling","volume":"167","author":"B Kojonazarov","year":"2013","journal-title":"International journal of cardiology"},{"issue":"1","key":"ref9","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1183\/09031936.00196511","article-title":"Thyroid hormone is highly permissive in angioproliferative pulmonary hypertension in rats","volume":"41","author":"A Al Husseini","year":"2013","journal-title":"European Respiratory Journal"},{"issue":"20","key":"ref10","doi-asserted-by":"crossref","first-page":"2081","DOI":"10.1161\/CIRCULATIONAHA.108.779751","article-title":"Combined tyrosine and serine\/threonine kinase inhibition by sorafenib prevents progression of experimental pulmonary hypertension and myocardial remodeling","volume":"118","author":"M Klein","year":"2008","journal-title":"Circulation"},{"issue":"10","key":"ref11","doi-asserted-by":"crossref","first-page":"2811","DOI":"10.1172\/JCI24838","article-title":"Reversal of experimental pulmonary hypertension by PDGF inhibition","volume":"115","author":"RT Schermuly","year":"2005","journal-title":"Journal of Clinical Investigation"},{"issue":"13","key":"ref12","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1056\/NEJMc051946","article-title":"Imatinib for the treatment of pulmonary arterial hypertension","volume":"353","author":"HA Ghofrani","year":"2005","journal-title":"New England Journal of Medicine"},{"issue":"9","key":"ref13","doi-asserted-by":"crossref","first-page":"1960","DOI":"10.1161\/ATVBAHA.107.146746","article-title":"Endothelin-1, but not Ang II, activates MAP kinases through c-Src\u2013independent Ras-Raf\u2013dependent pathways in vascular smooth muscle cells","volume":"27","author":"A Yogi","year":"2007","journal-title":"Arteriosclerosis, thrombosis, and vascular biology"},{"issue":"6","key":"ref14","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1161\/01.CIR.0000138190.50127.6A","article-title":"Raf-1 kinase is required for cardiac hypertrophy and cardiomyocyte survival in response to pressure overload","volume":"110","author":"IS Harris","year":"2004","journal-title":"Circulation"},{"issue":"5","key":"ref15","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1097\/FJC.0b013e3181f50a70","article-title":"Redox regulation of myocardial ERK 1\/2 phosphorylation in experimental hyperthyroidism: role of thioredoxin-peroxiredoxin system","volume":"56","author":"AS da Rosa Araujo","year":"2010","journal-title":"Journal of cardiovascular pharmacology"},{"issue":"11","key":"ref16","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1161\/CIRCULATIONAHA.112.094912","article-title":"Is inhibition of phosphodiesterase type 5 by sildenafil a promising therapy for volume-overload heart failure?","volume":"125","author":"W Dai","year":"2012","journal-title":"Circulation"},{"issue":"1","key":"ref17","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.jacc.2011.07.051","article-title":"Cardiac uses of phosphodiesterase-5 inhibitors","volume":"59","author":"BG Schwartz","year":"2012","journal-title":"Journal of the American College of Cardiology"},{"issue":"5","key":"ref18","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1517\/14656566.2012.662220","article-title":"Tadalafil for the treatment of pulmonary arterial hypertension","volume":"13","author":"MK Frey","year":"2012","journal-title":"Expert opinion on pharmacotherapy"},{"issue":"5","key":"ref19","doi-asserted-by":"crossref","first-page":"H1236","DOI":"10.1152\/ajpheart.00100.2009","article-title":"ERK phosphorylation mediates sildenafil-induced myocardial protection against ischemia-reperfusion injury in mice","volume":"296","author":"A Das","year":"2009","journal-title":"American Journal of Physiology-Heart and Circulatory Physiology"},{"issue":"11","key":"ref20","doi-asserted-by":"crossref","first-page":"S31","DOI":"10.1161\/CIRCULATIONAHA.108.843979","article-title":"Phosphodiesterase-5 inhibitor, tadalafil, protects against myocardial ischemia\/reperfusion through protein-kinase G\u2013dependent generation of hydrogen sulfide","volume":"120","author":"FN Salloum","year":"2009","journal-title":"Circulation"},{"issue":"3","key":"ref21","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1124\/jpet.110.170191","article-title":"Long-acting phosphodiesterase-5 inhibitor tadalafil attenuates doxorubicin-induced cardiomyopathy without interfering with chemotherapeutic effect","volume":"334","author":"S Koka","year":"2010","journal-title":"Journal of Pharmacology and Experimental Therapeutics"},{"issue":"2","key":"ref22","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.jjcc.2013.03.018","article-title":"The beneficial effects of tadalafil on left ventricular dysfunction in doxorubicin-induced cardiomyopathy","volume":"62","author":"Z Jin","year":"2013","journal-title":"Journal of cardiology"},{"issue":"6","key":"ref23","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1007\/s10557-014-6559-0","article-title":"Tadalafil Prevents Acute Heart Failure with Reduced Ejection Fraction in Mice","volume":"28","author":"FN Salloum","year":"2014","journal-title":"Cardiovascular Drugs and Therapy"},{"issue":"3","key":"ref24","doi-asserted-by":"crossref","first-page":"H1398","DOI":"10.1152\/ajpheart.91438.2007","article-title":"Sildenafil (Viagra) attenuates ischemic cardiomyopathy and improves left ventricular function in mice","volume":"294","author":"FN Salloum","year":"2008","journal-title":"American Journal of Physiology-Heart and Circulatory Physiology"},{"issue":"1","key":"ref25","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/1471-2210-5-10","article-title":"Sildenafil citrate increases myocardial cGMP content in rat heart, decreases its hypertrophic response to isoproterenol and decreases myocardial leak of creatine kinase and troponin T","volume":"5","author":"MA Hassan","year":"2005","journal-title":"BMC pharmacology"},{"issue":"44","key":"ref26","doi-asserted-by":"crossref","first-page":"19079","DOI":"10.1073\/pnas.1013077107","article-title":"Sildenafil reverses cardiac dysfunction in the mdx mouse model of Duchenne muscular dystrophy","volume":"107","author":"CM Adamo","year":"2010","journal-title":"Proceedings of the National Academy of Sciences"},{"issue":"2","key":"ref27","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.jacc.2008.08.069","article-title":"Sildenafil stops progressive chamber, cellular, and molecular remodeling and improves calcium handling and function in hearts with pre-existing advanced hypertrophy caused by pressure overload","volume":"53","author":"T Nagayama","year":"2009","journal-title":"Journal of the American College of Cardiology"},{"issue":"2","key":"ref28","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1038\/nm1175","article-title":"Chronic inhibition of cyclic GMP phosphodiesterase 5A prevents and reverses cardiac hypertrophy","volume":"11","author":"E Takimoto","year":"2005","journal-title":"Nature medicine"},{"issue":"2","key":"ref29","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1161\/HYPERTENSIONAHA.111.180968","article-title":"Sildenafil prevents and reverses transverse-tubule remodeling and Ca2+ handling dysfunction in right ventricle failure induced by pulmonary artery hypertension","volume":"59","author":"Y-P Xie","year":"2012","journal-title":"Hypertension"},{"issue":"3","key":"ref30","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1161\/CIRCULATIONAHA.106.655266","article-title":"Phosphodiesterase type 5 is highly expressed in the hypertrophied human right ventricle, and acute inhibition of phosphodiesterase type 5 improves contractility","volume":"116","author":"J Nagendran","year":"2007","journal-title":"Circulation"},{"issue":"1\u20132","key":"ref31","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1007\/s11010-007-9459-9","article-title":"Oxidative stress activates insulin-like growth factor I receptor protein expression, mediating cardiac hypertrophy induced by thyroxine","volume":"303","author":"A Araujo","year":"2007","journal-title":"Molecular and cellular biochemistry"},{"issue":"6","key":"ref32","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1677\/JME-08-0024","article-title":"The role of redox signaling in cardiac hypertrophy induced by experimental hyperthyroidism","volume":"41","author":"A Araujo","year":"2008","journal-title":"Journal of Molecular Endocrinology"},{"issue":"1","key":"ref33","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.mce.2010.12.018","article-title":"Reactive oxygen and nitrogen species balance in the determination of thyroid hormones-induced cardiac hypertrophy mediated by renin\u2013angiotensin system","volume":"333","author":"A Araujo","year":"2011","journal-title":"Molecular and cellular endocrinology"},{"issue":"1","key":"ref34","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.mce.2010.01.031","article-title":"Excessive thyroxine enhances susceptibility to apoptosis and decreases contractility of cardiomyocytes","volume":"320","author":"Y-Y Wang","year":"2010","journal-title":"Molecular and Cellular Endocrinology"},{"issue":"5","key":"ref35","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1097\/FJC.0000000000000296","article-title":"Comparison of Macitentan and Bosentan on Right Ventricular Remodeling in a Rat Model of Non-vasoreactive Pulmonary Hypertension","volume":"66","author":"M Iglarz","year":"2015","journal-title":"Journal of cardiovascular pharmacology"},{"issue":"2","key":"ref36","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1161\/01.CIR.0000105701.98663.D4","article-title":"Conditional cardiac overexpression of endothelin-1 induces inflammation and dilated cardiomyopathy in mice","volume":"109","author":"LL Yang","year":"2004","journal-title":"Circulation"},{"issue":"6163","key":"ref37","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1038\/332411a0","article-title":"A novel potent vasoconstrictor peptide produced by vascular endothelial cells","volume":"332","author":"M Yanagisawa","year":"1988","journal-title":"nature"},{"issue":"2","key":"ref38","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1161\/01.CIR.85.2.510","article-title":"Elevated endothelin-1 in heart failure and loss of normal response to postural change","volume":"85","author":"DJ Stewart","year":"1992","journal-title":"Circulation"},{"issue":"6","key":"ref39","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1161\/01.CIR.93.6.1214","article-title":"Endogenous Endothelin-1 Participates in the Maintenance of Cardiac Function in Rats With Congestive Heart Failure Marked Increase in Endothelin-1 Production in the Failing Heart","volume":"93","author":"S Sakai","year":"1996","journal-title":"Circulation"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"S294","DOI":"10.1097\/00005344-199800001-00082","article-title":"Coordinated upregulation of the cardiac endothelin system in a rat model of heart failure","volume":"31","author":"P Picard","year":"1998","journal-title":"Journal of cardiovascular pharmacology"},{"issue":"14","key":"ref41","doi-asserted-by":"crossref","first-page":"1802","DOI":"10.1161\/01.CIR.99.14.1802","article-title":"Functional effects of endothelin and regulation of endothelin receptors in isolated human nonfailing and failing myocardium","volume":"99","author":"B Pieske","year":"1999","journal-title":"Circulation"},{"issue":"5","key":"ref42","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1097\/FJC.0000000000000141","article-title":"Novel dual endothelin receptor antagonist macitentan reverses severe pulmonary arterial hypertension in rats","volume":"64","author":"M Kunita-Takanezawa","year":"2014","journal-title":"Journal of cardiovascular pharmacology"},{"issue":"12","key":"ref43","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1056\/NEJMoa012212","article-title":"Bosentan therapy for pulmonary arterial hypertension","volume":"346","author":"LJ Rubin","year":"2002","journal-title":"New England Journal of Medicine"},{"issue":"9","key":"ref44","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1056\/NEJMoa1213917","article-title":"Macitentan and morbidity and mortality in pulmonary arterial hypertension","volume":"369","author":"T Pulido","year":"2013","journal-title":"New England Journal of Medicine"},{"issue":"2","key":"ref45","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.lfs.2014.02.018","article-title":"Comparison of pharmacological activity of macitentan and bosentan in preclinical models of systemic and pulmonary hypertension","volume":"118","author":"M Iglarz","year":"2014","journal-title":"Life sciences"},{"issue":"7","key":"ref46","doi-asserted-by":"crossref","first-page":"2088","DOI":"10.1073\/pnas.0307159101","article-title":"Mice with cardiomyocyte-specific disruption of the endothelin-1 gene are resistant to hyperthyroid cardiac hypertrophy","volume":"101","author":"RV Shohet","year":"2004","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"4","key":"ref47","first-page":"524","article-title":"CPU0213, a novel endothelin receptor antagonist, suppresses the upregulation of matrix metalloproteinases and connexin 43 in hyperthyroid myocardium","volume":"60","author":"X-Y Tang","year":"2008","journal-title":"Pharmacological Reports"},{"issue":"3","key":"ref48","first-page":"306","article-title":"Endothelin receptor antagonist CPU0213 suppresses ventricular fibrillation in L-thyroxin induced cardiomyopathy","volume":"59","author":"Y Feng","year":"2007","journal-title":"Pharmacological Reports"},{"issue":"3","key":"ref49","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.ijcard.2008.05.018","article-title":"Downregulated FKBP12. 6 expression and upregulated endothelin signaling contribute to elevated diastolic calcium and arrhythmogenesis in rat cardiomyopathy produced by l-thyroxin","volume":"130","author":"Y Zhang","year":"2008","journal-title":"International journal of cardiology"},{"issue":"8","key":"ref50","doi-asserted-by":"crossref","first-page":"e42500","DOI":"10.1371\/journal.pone.0042500","article-title":"Rac-induced left ventricular dilation in thyroxin-treated ZmRacD transgenic mice: role of cardiomyocyte apoptosis and myocardial fibrosis","volume":"7","author":"MT Elnakish","year":"2012","journal-title":"PloS one"},{"issue":"6","key":"ref51","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1097\/FJC.0b013e31828d4b9d","article-title":"Myocardial Rac1 exhibits partial involvement in thyroxin-induced cardiomyocyte hypertrophy and its inhibition is not sufficient to improve cardiac dysfunction or contractile abnormalities in mouse papillary muscles","volume":"61","author":"MT Elnakish","year":"2013","journal-title":"Journal of cardiovascular pharmacology"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.freeradbiomed.2015.02.035","article-title":"Differential involvement of various sources of reactive oxygen species in thyroxin-induced hemodynamic changes and contractile dysfunction of the heart and diaphragm muscles","volume":"83","author":"MT Elnakish","year":"2015","journal-title":"Free Radical Biology and Medicine"},{"issue":"11","key":"ref53","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1161\/CIRCRESAHA.114.303200","article-title":"Sorafenib cardiotoxicity increases mortality after myocardial infarction","volume":"114","author":"JM Duran","year":"2014","journal-title":"Circulation research"},{"key":"ref54","article-title":"Effects of Sorafenib Dose on Acquired Reversible Resistance and Toxicity in Hepatocellular Carcinoma","author":"EA Kuczynski","year":"2015","journal-title":"Cancer research"},{"key":"ref55","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0045243","article-title":"Anti-inflammatory and cardioprotective effects of tadalafil in diabetic mice","author":"A Varma","year":"2012"},{"issue":"3\u20134","key":"ref56","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1007\/s10974-014-9386-9","article-title":"Decrease in sarcoplasmic reticulum calcium content, not myofilament function, contributes to muscle twitch force decline in isolated cardiac trabeculae","volume":"35","author":"N Milani-Nejad","year":"2014","journal-title":"Journal of muscle research and cell motility"},{"issue":"1","key":"ref57","doi-asserted-by":"crossref","first-page":"H293","DOI":"10.1152\/ajpheart.1992.263.1.H293","article-title":"A method to reconstruct myocardial sarcomere lengths and orientations at transmural sites in beating canine hearts","volume":"263","author":"EK Rodriguez","year":"1992","journal-title":"American Journal of Physiology-Heart and Circulatory Physiology"},{"issue":"5","key":"ref58","doi-asserted-by":"crossref","first-page":"R1376","DOI":"10.1152\/ajpregu.00722.2005","article-title":"Effects of chronic treatment with 7-nitroindazole in hyperthyroid rats","volume":"291","author":"R Wangensteen","year":"2006","journal-title":"American Journal of Physiology-Regulatory, Integrative and Comparative Physiology"},{"issue":"5","key":"ref59","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1111\/j.1755-5922.2011.00278.x","article-title":"Sunitinib, a receptor tyrosine kinase inhibitor, increases blood pressure in rats without associated changes in cardiac structure and function","volume":"30","author":"E Blasi","year":"2012","journal-title":"Cardiovascular therapeutics"},{"issue":"2","key":"ref60","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1152\/physiolgenomics.00169.2007","article-title":"Genomic assessment of a multikinase inhibitor, sorafenib, in a rodent model of pulmonary hypertension","volume":"33","author":"L Moreno-Vinasco","year":"2008","journal-title":"Physiological genomics"},{"key":"ref61","doi-asserted-by":"crossref","unstructured":"Maitland M, Moshier K, Imperial J, Kasza K, Karrison T, Elliott W, et al., editors. Blood pressure (BP) as a biomarker for sorafenib (S), an inhibitor of the vascular endothelial growth factor (VEGF) signaling pathway. ASCO Annual Meeting Proceedings; 2006.","DOI":"10.1200\/jco.2006.24.18_suppl.2035"},{"issue":"4","key":"ref62","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1185\/030079903125001839","article-title":"Sildenafil in erectile dysfunction: a critical review","volume":"19","author":"A Salonia","year":"2003","journal-title":"Current Medical Research and Opinion\u00ae"},{"issue":"1","key":"ref63","first-page":"1","article-title":"Inhibition of phosphodiesterase 5 restores endothelial function in renovascular hypertension","volume":"12","author":"AT Dias","year":"2014","journal-title":"Journal of translational medicine"},{"issue":"10","key":"ref64","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1038\/sj.jhh.1001244","article-title":"Effect of sildenafil on blood pressure and arterial wave reflection in treated hypertensive men","volume":"15","author":"A Mahmud","year":"2001","journal-title":"Journal of human hypertension"},{"issue":"5","key":"ref65","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1161\/HYPERTENSIONAHA.111.186270","article-title":"Sildenafil citrate rescues fetal growth in the catechol-O-methyl transferase knockout mouse model","volume":"59","author":"JL Stanley","year":"2012","journal-title":"Hypertension"},{"issue":"2","key":"ref66","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1046\/j.1365-2125.2003.01974.x","article-title":"Sildenafil does not improve nitric oxide\u2010mediated endothelium\u2010dependent vascular responses in smokers","volume":"57","author":"V Dishy","year":"2004","journal-title":"British journal of clinical pharmacology"},{"issue":"11","key":"ref67","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1007\/s40618-014-0177-3","article-title":"Efficacy of sorafenib and impact on cardiac function in patients with thyroid cancer: a retrospective analysis","volume":"37","author":"L Mortara","year":"2014","journal-title":"Journal of endocrinological investigation"},{"issue":"6","key":"ref68","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1200\/JCO.2009.24.9730","article-title":"Association of skeletal muscle wasting with treatment with sorafenib in patients with advanced renal cell carcinoma: results from a placebo-controlled study","volume":"28","author":"S Antoun","year":"2010","journal-title":"Journal of clinical oncology"},{"issue":"12","key":"ref69","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1016\/j.ejheart.2008.09.016","article-title":"Effects of phosphodiesterase\u20105 inhibition by sildenafil in the pressure overloaded right heart","volume":"10","author":"A Andersen","year":"2008","journal-title":"European journal of heart failure"},{"issue":"35","key":"ref70","doi-asserted-by":"crossref","first-page":"12925","DOI":"10.1073\/pnas.1414364111","article-title":"Roles of cGMP-dependent protein kinase I (cGKI) and PDE5 in the regulation of Ang II-induced cardiac hypertrophy and fibrosis","volume":"111","author":"E Patrucco","year":"2014","journal-title":"Proceedings of the National Academy of Sciences"},{"issue":"1","key":"ref71","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1210\/endo-107-1-6","article-title":"Thyroxine-Induced Changes in Characteristics and Activities of \u03b2-Adrenergic Receptors and Adenosine 3\u2032, 5\u2032-Monophosphate and Guanosine 3\u2032, 5\u2032-Monophosphate Systems in the Heart May Be Related to Reputed Catecholamine Supersensitivity in Hyperthyroidism*","volume":"107","author":"J TSE","year":"1980","journal-title":"Endocrinology"},{"issue":"2","key":"ref72","doi-asserted-by":"crossref","first-page":"H686","DOI":"10.1152\/ajpheart.1995.268.2.H686","article-title":"Relationship between cGMP and myocardial O2 consumption is altered in T4-induced cardiac hypertrophy","volume":"268","author":"HR Weiss","year":"1995","journal-title":"American Journal of Physiology-Heart and Circulatory Physiology"},{"issue":"9","key":"ref73","doi-asserted-by":"crossref","first-page":"2276","DOI":"10.1016\/j.peptides.2006.04.011","article-title":"T4-induced cardiac hypertrophy disrupts cyclic GMP mediated responses to brain natriuretic peptide in rabbit myocardium","volume":"27","author":"E Katz","year":"2006","journal-title":"peptides"},{"issue":"5","key":"ref74","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1161\/01.RES.65.5.1361","article-title":"Decreased cardiac concentration of cGMP kinase in hypertensive animals. An index for cardiac vascularization?","volume":"65","author":"T Ecker","year":"1989","journal-title":"Circulation research"},{"issue":"12","key":"ref75","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1111\/j.1440-1681.2003.03936.x","article-title":"Cyclic GMP protein kinase activity is reduced in thyroxine\u2010induced hypertrophic cardiac myocytes","volume":"30","author":"L Yan","year":"2003","journal-title":"Clinical and experimental pharmacology and physiology"},{"issue":"1","key":"ref76","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0014-2999(01)00993-1","article-title":"Negative functional effects of cGMP mediated by cGMP protein kinase are reduced in T 4 cardiac myocytes","volume":"421","author":"S Engel","year":"2001","journal-title":"European journal of pharmacology"},{"issue":"13","key":"ref77","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/j.lfs.2012.02.006","article-title":"ET-1 from endothelial cells is required for complete angiotensin II-induced cardiac fibrosis and hypertrophy","volume":"91","author":"S Adiarto","year":"2012","journal-title":"Life sciences"},{"issue":"3","key":"ref78","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1161\/01.HYP.33.3.816","article-title":"Endothelin system\u2013dependent cardiac remodeling in renovascular hypertension","volume":"33","author":"B Hocher","year":"1999","journal-title":"Hypertension"},{"issue":"22","key":"ref79","doi-asserted-by":"crossref","first-page":"8226","DOI":"10.1128\/MCB.23.22.8226-8232.2003","article-title":"Cardiomyocyte-specific endothelin A receptor knockout mice have normal cardiac function and an unaltered hypertrophic response to angiotensin II and isoproterenol","volume":"23","author":"RM Kedzierski","year":"2003","journal-title":"Molecular and Cellular Biology"},{"issue":"2","key":"ref80","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0088730","article-title":"Vascular endothelium derived endothelin-1 is required for normal heart function after chronic pressure overload in mice","volume":"9","author":"S Heiden","year":"2014","journal-title":"PloS one"},{"issue":"9431","key":"ref81","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/S0140-6736(04)16723-8","article-title":"Long-term effects of darusentan on left-ventricular remodelling and clinical outcomes in the Endothelin A Receptor Antagonist Trial in Heart Failure (EARTH): randomised, double-blind, placebo-controlled trial","volume":"364","author":"I Anand","year":"2004","journal-title":"The Lancet"},{"issue":"9","key":"ref82","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1016\/S0735-1097(03)00194-3","article-title":"Tezosentan in patients with acuteheart failure and acute coronary syndromes: Results of the randomized intravenous tezosentan study (ritz-4)","volume":"41","author":"CM O\u2019Connor","year":"2003","journal-title":"Journal of the American College of Cardiology"},{"issue":"1","key":"ref83","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1172\/JCI116579","article-title":"Endothelin-1 is an autocrine\/paracrine factor in the mechanism of angiotensin II-induced hypertrophy in cultured rat cardiomyocytes","volume":"92","author":"H Ito","year":"1993","journal-title":"Journal of Clinical Investigation"},{"issue":"11","key":"ref84","doi-asserted-by":"crossref","first-page":"2068","DOI":"10.1161\/01.CIR.93.11.2068","article-title":"Endothelin-1 is involved in norepinephrine-induced ventricular hypertrophy in vivo Acute effects of bosentan, an orally active, mixed endothelin ETA and ETB receptor antagonist","volume":"93","author":"S Kaddoura","year":"1996","journal-title":"Circulation"},{"issue":"1","key":"ref85","doi-asserted-by":"crossref","first-page":"H88","DOI":"10.1152\/ajpheart.1996.271.1.H88","article-title":"Effect of endothelin antagonism on blood pressure and vascular structure in renovascular hypertensive rats","volume":"271","author":"J Li","year":"1996","journal-title":"American Journal of Physiology-Heart and Circulatory Physiology"},{"key":"ref86","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1002\/9780470942390.mo100159","article-title":"Heart rate and electrocardiography monitoring in mice","author":"D Ho","year":"2011","journal-title":"Current protocols in mouse biology"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0153694","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,17]],"date-time":"2022-06-17T23:04:46Z","timestamp":1655507086000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0153694"}},"subtitle":[],"editor":[{"given":"Vincenzo","family":"Lionetti","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2016,4,15]]},"references-count":86,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2016,4,15]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0153694","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,4,15]]}}}